Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Unproven Cell-Based Therapies
2:32
The ISCT’s ongoing battle against unproven cell & gene therapies
Miguel Forte
• 5 Oct 2021
7:29
Tackling unproven cell-based therapies and the impact of COVID-19
Aaron Levine
• 28 May 2021
4:33
ISCT 2021 highlights: therapeutic deception, global regulation & CAR-T
Aaron Levine
• 28 May 2021
3:29
Direct-to-consumer marketing of unproven orthopedic therapies
Nicolas Piuzzi
• 7 Jun 2021
3:14
Addressing the unproven cell-based therapy market
Miguel Forte
• 26 May 2021
2:22
Tackling therapeutic deception in unproven therapies: highlights from ISCT 2021
Laertis Ikonomou
• 25 May 2021
2:22
The current landscape of unproven cell-based therapies
Laertis Ikonomou
• 25 May 2021
4:09
Anticipating a crackdown on unproven cell-based therapies
Laertis Ikonomou
• 25 May 2021
